1. Home
  2. KFRC vs AURA Comparison

KFRC vs AURA Comparison

Compare KFRC & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kforce Inc.

KFRC

Kforce Inc.

HOLD

Current Price

$30.96

Market Cap

470.6M

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$5.85

Market Cap

396.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KFRC
AURA
Founded
1962
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
470.6M
396.8M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
KFRC
AURA
Price
$30.96
$5.85
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$34.75
$20.20
AVG Volume (30 Days)
251.2K
174.4K
Earning Date
02-02-2026
11-13-2025
Dividend Yield
5.03%
N/A
EPS Growth
N/A
N/A
EPS
2.26
N/A
Revenue
$1,340,771,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.49
$4.35
52 Week High
$57.60
$8.60

Technical Indicators

Market Signals
Indicator
KFRC
AURA
Relative Strength Index (RSI) 55.55 45.10
Support Level $30.37 $5.73
Resistance Level $31.75 $6.15
Average True Range (ATR) 0.98 0.27
MACD -0.00 -0.06
Stochastic Oscillator 65.09 16.49

Price Performance

Historical Comparison
KFRC
AURA

About KFRC Kforce Inc.

Kforce Inc is a solutions firm specializing in technology, finance and accounting, and other professional staffing services. The company operates two business segments: 1) In technology segment it provides talent solutions with candidates skilled in areas including systems/applications architecture and development, data management and analytics, business and artificial intelligence, machine learning, project and program management, and network architecture and security. 2) In FA segment company offers consultants in traditional finance and accounting roles such as finance, planning and analysis; business intelligence analysis; general accounting; transactional accounting business and cost analysis; and taxation and treasury. The majority of revenue is earned through the technology segment.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: